Disclaimer
Educational use only. No medical advice.
All content on Immortal Peps (immortalpeps.online) is provided strictly for educational and informational purposes. The information presented is based on published, peer-reviewed research and is intended to support understanding of research compounds, biohacking concepts, and longevity science — not to guide personal use.
Not medical advice
Nothing on this site constitutes medical, pharmaceutical, or clinical advice. Immortal Peps does not diagnose, treat, cure, or prevent any disease. The information presented here is not a substitute for consultation with a licensed medical professional.
Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition, treatment, supplement, or compound. Never disregard professional medical advice or delay in seeking it because of something you have read on this site.
Research context only
All compounds discussed on Immortal Peps are presented in the context of scientific research — typically preclinical (in vitro or animal model) studies, unless otherwise stated.
Where human trials exist, the specific population, sample size, primary endpoint, and limitations are noted. We do not extrapolate findings from a Phase 2 trial in 60 patients with type 2 diabetes into “this peptide is generally safe for healthy people” — and neither should you.
Regulatory status
Most compounds discussed on this site are not approved by the FDA, EMA, MHRA, or equivalent regulatory bodies for the purposes for which they are marketed online. Many are explicitly sold “for research use only” and are not lawful for human consumption outside specific licensed indications.
Where a compound is approved for a specific indication (e.g., semaglutide for type 2 diabetes, bremelanotide for hypoactive sexual desire disorder), we note it clearly and reference the relevant regulatory framework. That approval does not extend to other indications, populations, or contexts.
No endorsement of off-label use
Immortal Peps does not endorse off-label human use of any compound. Off-label use — using an approved drug for an unapproved indication — is a clinical decision that must be made between a patient and their prescriber, with full awareness of the underlying evidence base and risks.
No protocols, no dosing
Immortal Peps does not publish dosing protocols, route-of-administration guidance, or reconstitution instructions. Such information belongs in clinical guidelines, product labelling, or — where appropriate — peer-reviewed dosing research.
We do not provide guidance on preparation, handling beyond storage, or use of any compound.
No supply, no recommendation
Immortal Peps is not a retailer, supplier, or referral service. We do not sell, ship, or distribute any compound discussed on this site. Where links to suppliers or compound databases appear, they are presented for context and educational reference — never as a recommendation.
Children and vulnerable populations
The content on this site is intended for adult researchers, students, clinicians, and informed readers. It is not directed at children. No content should be interpreted as a recommendation for use by pregnant or breastfeeding individuals, individuals with serious medical conditions, or any other vulnerable population.
Accuracy and updates
Research evolves. We make reasonable efforts to keep our content accurate and current, but we make no warranties about the completeness, reliability, or timeliness of the information presented. Readers are responsible for verifying claims against the primary sources we link to.
Limitation of liability
Immortal Peps, its editors, contributors, and affiliates shall not be liable for any direct, indirect, incidental, consequential, or special damages arising out of or in connection with the use of, or inability to use, the information on this site.
Jurisdiction
This site is operated from the European Union. Content is provided globally for educational access. Local regulations regarding compound possession, research, and clinical use vary by jurisdiction. Readers are responsible for understanding the regulations that apply to them.